Evidence map›Paper›PMID 25208846›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2014

ADP-induced bladder contractility is mediated by P2Y12 receptor and temporally regulated by ectonucleotidases and adenosine signaling.

Weiqun Yu, Xiaofeng Sun, Simon C Robson, Warren G Hill

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Dysregulation of CD39/Ectonucleoside Triphosphate Diphosphohydrolase 1 Causes Urinary Bladder Dysfunction with Abnormal Smooth Muscle Contractility.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Ectonucleotidases and purinergic receptors in mouse prostate gland.American journal of clinical and experimental urology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Molecular mechanisms of voiding dysfunction in a novel mouse model of acute urinary retention.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Urothelial purine release during filling of murine and primate bladders.American journal of physiology. Renal physiology · 2016
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Weiqun YuLaboratory of Voiding Dysfunction, Division of Nephrology, and wyu2@bidmc.harvard.edu.
Xiaofeng SunDivision of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Simon C RobsonDivision of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Warren G HillLaboratory of Voiding Dysfunction, Division of Nephrology, and.
Beth Israel Deaconess Medical Center · USHarvard University · US

Funding

XENOGRAFT TOLERANCE THROUGH MIXED CHIMERISMP01AI045897 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Megan Sykes · 2000 to 2026
$71.9M
Role of Integrins in Bladder UrotheliumR01DK083299 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HILL, WARREN G. · 2010 to 2014
$1.8M
Purinergic Regulation of Bladder Interstitial Cells of CajalR00DK095922 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI YU, WEIQUN · 2015 to 2017
$747k
Engineering Inhibitory Antibodies to Ectoenzymes for Cancer TreatmentR21CA164970 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ROBSON, SIMON C. · 2012 to 2013
$405k
Purinergic Regulation of Bladder Interstitial Cells of CajalK99DK095922 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI YU, WEIQUN · 2013 to 2014
$180k
NCI NIH HHS CA164970NCI NIH HHS R21 CA164970NIAID NIH HHS AI045897NIAID NIH HHS P01 AI045897NIDDK NIH HHS DK-083299NIDDK NIH HHS DK-095922NIDDK NIH HHS K99 DK095922NIDDK NIH HHS R00 DK095922NIDDK NIH HHS R01 DK083299
6 · The paper itself

Abstract

Purinergic signaling comprises one key pathway in modulating bladder smooth muscle (BSM) contractility, disorders of which become highly prevalent with aging. ADP was first observed to modulate BSM contractility >40 yr ago, yet the underlying molecular mechanism still remains unclear. Here, we demonstrate, using myography, that ADP and ADPβS dose-dependently induce mouse BSM contraction, and ADP-induced BSM contraction is blocked by a selective P2Y12 receptor (P2Y12R) antagonist, PSB 0739 (25 μM), but is unaffected by P2Y1 and P2Y13 receptor antagonists. P2Y12R in BSM exhibits distinct pharmacological properties that are different from P2Y12R in platelets. After an immediate contraction, prolonged exposure to ADP causes BSM to become refractory to further ADP-mediated contraction. However, in mice lacking ectonucleotidases Entpd1 (ATP→ADP→AMP) or Nt5e (AMP→adenosine), or by inhibiting adenosine signaling, the refractory response was altered, resulting in repeated BSM contractions in response to repeated ADP (0.1-1 mM) stimulation. Our data indicate that P2Y12R undergoes slow desensitization; ADP-P2Y12 signaling is tightly regulated by Entpd1/Nt5e activity and adenosine receptors; and ADP-adenosine signaling play an important role in modulating P2X-mediated BSM contraction. The identification of P2Y12R in BSM, and the current clinical availability of P2Y12R inhibitors, such as clopidogrel, offers potentially novel treatment strategies for bladder contractility disorders.

Indexed as

AdenosineAdenosine DiphosphateAdenosine TriphosphatasesAnimalsElectric StimulationMiceMice, Inbred C57BLMice, KnockoutMuscle ContractionReceptors, Purinergic P2Y12Signal TransductionUrinary BladderAdenosineAdenosine DiphosphateAdenosine TriphosphatasesectoATPaseP2ry12 protein, mouseReceptors, Purinergic P2Y12detrusormechanotransductionmicturitionmyographyurinary tract

Identifiers

PMID25208846
PMCPMC4232283
OpenAlexW2171006813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.